The comparative study between direct renin inhibitor and angiotensin II receptor antagonist in hypertensive patients with chronic kidney disease

Trial Profile

The comparative study between direct renin inhibitor and angiotensin II receptor antagonist in hypertensive patients with chronic kidney disease

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2012

At a glance

  • Drugs Aliskiren (Primary) ; Valsartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jul 2012 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 18 Jul 2012 Actual initiation date (Oct 2010) added as reported by University Hospital Medical Information Network - Japan.
    • 10 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top